造影剂肾病的相关临床研究进展
Progress of Related Clinical Research on Contrast Induced Nephropathy
DOI: 10.12677/acm.2024.1441039, PDF,   
作者: 李寒松：赣南医科大学第一临床医学院，江西 赣州；廖永玲：赣南医科大学第一附属医院，江西 赣州
关键词: 造影剂肾病；危险因素；早期诊断；预防；Contrast Induced Nephropathy； Risk Factors； Early Diagnosis； Prevention
摘要: 随着冠脉介入诊疗术和增强CT在临床中的广泛应用，国内使用造影剂的人群每年达到2~3千万人，造影剂肾病(Contrast Induced Nephropathy, CIN)发生率为1%~5%，每年发生CIN约20~100万例。目前针对CIN并无有效治疗方法，所以临床医生的主要目标是预防，合理使用造影剂及充分水化被认为是最有效的预防手段。本文就CIN诊断标准、危险因素、早期诊断及预防进行综述。
Abstract: With the extensive clinical application of coronary interventional diagnosis and treatment and enhanced CT, the number of people using contrast media in China reaches 20~30 million each year, and the incidence of Contrast Induced Nephropathy (CIN) is 1%~5%, with about 200,000 to 1 million cases of CIN occurring every year. At present, there is no effective treatment for CIN, so the main goal of clinicians is prevention, and rational use of contrast media and adequate hydration are considered to be the most effective means of prevention. This article reviews the diagnostic criteria, risk factors, early diagnosis and prevention of CIN.
文章引用：李寒松, 廖永玲. 造影剂肾病的相关临床研究进展[J]. 临床医学进展, 2024, 14(4): 422-429. https://doi.org/10.12677/acm.2024.1441039

参考文献

[1] Katzberg, R.W. and Lamba, R. (2009) Contrast-Induced Nephropathy after Intravenous Administration: Fact or Fiction? Radiologic Clinics, 47, 789-800. [Google Scholar] [CrossRef] [PubMed]
[2] Hou, S.H., Bushinsky, D.A., Wish, J.B., et al. (1983) Hospital-Acquired Renal Insufficiency: A Prospective Study. The American Journal of Medicine, 74, 243-248. [Google Scholar] [CrossRef] [PubMed]
[3] Van Der Molen, A.J., Reimer, P., Dekkers, I.A., et al. (2018) Post-Contrast Acute Kidney Injury—Part 1: Definition, Clinical Features, Incidence, Role of Contrast Medium and Risk Factors: Recommendations for Updated ESUR Contrast Medium Safety Committee Guidelines. European Radiology, 28, 2845-2855. [Google Scholar] [CrossRef] [PubMed]
[4] Kellum, J.A. and Lameire, N. (2013) Diagnosis, Evaluation, and Management of Acute Kidney Injury: A KDIGO Summary (Part 1). Critical Care, 17, Article No. 204. [Google Scholar] [CrossRef] [PubMed]
[5] Mehran, R., Aymong, E.D., Nikolsky, E., et al. (2004) A Simple Risk Score for Prediction of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention: Development and Initial Validation. Journal of the American College of Cardiology, 44, 1393-1399. [Google Scholar] [CrossRef] 
[6] Abe, M., Morimoto, T., Akao, M., et al. (2014) Relation of Contrast-Induced Nephropathy to Long-Term Mortality after Percutaneous Coronary Intervention. The American Journal of Cardiology, 114, 362-368. [Google Scholar] [CrossRef] [PubMed]
[7] Heyman, S.N., Rosenberger, C., Rosen, S., et al. (2013) Why Is Diabetes Mellitus a Risk Factor for Contrast-Induced Nephropathy? BioMed Research International, 2013, Article ID: 123589. [Google Scholar] [CrossRef] [PubMed]
[8] Wong, P.C., Li, Z., Guo, J., et al. (2012) Pathophysiology of Contrast-Induced Nephropathy. International Journal of Cardiology, 158, 186-192. [Google Scholar] [CrossRef] [PubMed]
[9] Toprak, O., Cirit, M., Yesil, M., et al. (2007) Impact of Diabetic and Pre-Diabetic State on Development of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease. Nephrology Dialysis Transplantation, 22, 819-826. [Google Scholar] [CrossRef] [PubMed]
[10] Nikolsky, E., Mehran, R., Turcot, D., et al. (2004) Impact of Chronic Kidney Disease on Prognosis of Patients with Diabetes Mellitus Treated with Percutaneous Coronary Intervention. The American Journal of Cardiology, 94, 300-305. [Google Scholar] [CrossRef] [PubMed]
[11] Bansal, S., andPatel, R.N. (2020) Pathophysiology of Contrast-Induced Acute Kidney Injury. Interventional Cardiology Clinics, 9, 293-298. [Google Scholar] [CrossRef] [PubMed]
[12] Maioli, M., Toso, A., Gallopin, M., et al. (2010) Preprocedural Score for Risk of Contrast-Induced Nephropathy in Elective Coronary Angiography and Intervention. Journal of Cardiovascular Medicine, 11, 444-449. [Google Scholar] [CrossRef] 
[13] Scoditti, E., Massaro, M. and Montinari, M.R. (2013) Endothelial Safety of Radiological Contrast Media: Why Being Concerned. Vascular Pharmacology, 58, 48-53. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, F., Lu, Z. and Wang, F. (2020) Advances in the Pathogenesis and Prevention of Contrast-Induced Nephropathy. Life Sciences, 259, Article ID: 118379. [Google Scholar] [CrossRef] [PubMed]
[15] Davidson, C., Stacul, F., McCullough, P.A., et al. (2006) Contrast Medium Use. The American Journal of Cardiology, 98, 42-58. [Google Scholar] [CrossRef] [PubMed]
[16] Hossain, M.A., Costanzo, E., Cosentino, J., et al. (2018) Contrast-Induced Nephropathy: Pathophysiology, Risk Factors, and Prevention. Saudi Journal of Kidney Diseases and Transplantation, 29, 1-9. [Google Scholar] [CrossRef] [PubMed]
[17] Kane, G.C., Doyle, B.J., Lerman, A., et al. (2008) Ultra-Low Contrast Volumes Reduce Rates of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Coronary Angiography. Journal of the American College of Cardiology, 51, 89-90. [Google Scholar] [CrossRef] [PubMed]
[18] Lameire, N., Biesen, W.V. and Vanholder, R. (2008) Acute Kidney Injury. Lancet, 372, 1863-1865. [Google Scholar] [CrossRef] 
[19] Urbschat, A., Obermuller, N. and Haferkamp, A. (2011) Biomarkers of Kidney Injury. Biomarkers, 16, S22-S30. [Google Scholar] [CrossRef] 
[20] Ferguson, T.W., Komenda, P. and Tangri, N. (2015) Cystatin C as a Biomarker for Estimating Glomerular Filtration Rate. Current Opinion in Nephrology and Hypertension, 24, 295-300. [Google Scholar] [CrossRef] 
[21] Wang, M., Zhang, L., Yue, R., et al. (2016) Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography. Medical Science Monitor, 22, 2956-2961. [Google Scholar] [CrossRef] 
[22] Singer, E., Marko, L., Paragas, N., et al. (2013) Neutrophil Gelatinase-Associated Lipocalin: Pathophysiology and Clinical Applications. Acta Physiologica, 207, 663-672. [Google Scholar] [CrossRef] [PubMed]
[23] Li, H., Yu, Z., Gan, L., et al. (2018) Serum NGAL and FGF23 May Have Certain Value in Early Diagnosis of CIN. Renal Failure, 40, 547-553. [Google Scholar] [CrossRef] 
[24] Liao, B., Nian, W., Xi, A., et al. (2019) Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN). Medical Science Monitor, 25, 565-570. [Google Scholar] [CrossRef] 
[25] He, Y., Deng, Y., Zhuang, K., et al. (2020) Predictive Value of Cystatin C and Neutrophil Gelatinase-Associated Lipocalin in Contrast-Induced Nephropathy: A Meta-Analysis. PLOS ONE, 15, e0230934. [Google Scholar] [CrossRef] [PubMed]
[26] Li, Q., Huang, Y., Shang, W., et al. (2020) The Predictive Value of Urinary Kidney Injury Molecular 1 for the Diagnosis of Contrast-Induced Acute Kidney Injury after Cardiac Catheterization: A Meta-Analysis. Journal of Interventional Cardiology, 2020, Article ID: 4982987. [Google Scholar] [CrossRef] [PubMed]
[27] Akdeniz, D., Celik, H.T., Kazanci, F., et al. (2015) Is Kidney Injury Molecule 1 a Valuable Tool for the Early Diagnosis of Contrast-Induced Nephropathy? Journal of Investigative Medicine, 63, 930-934. [Google Scholar] [CrossRef] 
[28] Wybraniec, M.T., Chudek, J., Bozentowicz-Wikarek, M., et al. (2017) Prediction of Contrast-Induced Acute Kidney Injury by Early Post-Procedural Analysis of Urinary Biomarkers and Intra-Renal Doppler Flow Indices in Patients Undergoing Coronary Angiography. Journal of Interventional Cardiology, 30, 465-472. [Google Scholar] [CrossRef] [PubMed]
[29] Yin, W., Kumar, T., Lai, Z., et al. (2019) Kidney Injury Molecule-1, a Sensitive and Specific Marker for Identifying Acute Proximal Tubular Injury, Can Be Used to Predict Renal Functional Recovery in Native Renal Biopsies. International Urology and Nephrology, 51, 2255-2265. [Google Scholar] [CrossRef] [PubMed]
[30] Yin, C. and Wang, N. (2016) Kidney Injury Molecule-1 in Kidney Disease. Renal Failure, 38, 1567-1573. [Google Scholar] [CrossRef] 
[31] Saliminejad, K., Khorram Khorshid, H.R., Soleymani Fard, S., et al. (2019) An Overview of MicroRNAs: Biology, Functions, Therapeutics, and Analysis Methods. Journal of Cellular Physiology, 234, 5451-5465. [Google Scholar] [CrossRef] [PubMed]
[32] Bhaskaran, M. and Mohan, M. (2014) MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease. Veterinary Pathology, 51, 759-774. [Google Scholar] [CrossRef] [PubMed]
[33] Sun, S.Q., Zhang, T., Ding, D., et al. (2016) Circulating MicroRNA-188,-30a, and-30e as Early Biomarkers for Contrast-Induced Acute Kidney Injury. Journal of the American Heart Association, 5, e004138. [Google Scholar] [CrossRef] 
[34] Pistolesi, V., Regolisti, G., Morabito, S., et al. (2018) Contrast Medium Induced Acute Kidney Injury: A Narrative Review. Journal of Nephrology, 31, 797-812. [Google Scholar] [CrossRef] [PubMed]
[35] Nijssen, E.C., Rennenberg, R.J., Nelemans, P.J., et al. (2017) Prophylactic Hydration to Protect Renal Function from Intravascular Iodinated Contrast Material in Patients at High Risk of Contrast-Induced Nephropathy (AMACING): A Prospective, Randomised, Phase 3, Controlled, Open-Label, Non-Inferiority Trial. The Lancet, 389, 1312-1322. [Google Scholar] [CrossRef] 

为你推荐